No business in the Philippines may manufacture, import, export, distribute, or sell a health product without first securing a License to Operate from the Food and Drug Administration. It is the gateway authorization for the entire regulated supply chain: without it, products cannot be registered, shipments cannot be released by customs, and retail or online listings expose the seller to administrative action.
The rules governing this license have changed materially in the last two years. Administrative Order No. 2024-0015, issued in November 2024, repealed the previous unified licensing order and reset validity periods, renewal mechanics, qualified person obligations, and the consequences of filing late. Filing has moved almost entirely online, and the renewal window itself was widened and then narrowed again inside a single year. Companies still working from older checklists routinely discover the gap at the worst possible moment, which is when their license has already lapsed. Understanding the current framework for the FDA license to operate is now a core compliance competency rather than a one-time administrative errand.
The Growing Importance of the FDA License to Operate
Three developments explain why licensing has become a board-level concern rather than a clerical task.
The legal foundation is Republic Act No. 9711, the Food and Drug Administration Act of 2009, which strengthened the agency’s regulatory and enforcement powers over food, drugs, cosmetics, medical devices, and household hazardous substances. Its implementing rules also supply the basis for the surcharges and penalties imposed on late licensing submissions, meaning the cost of poor compliance calendars is written directly into law.
The second development is the streamlining mandate. Republic Act No. 11032, the Ease of Doing Business and Efficient Government Service Delivery Act of 2018, pushed the agency toward simplified, automated processing. That produced Administrative Order No. 2020-0017, followed by Administrative Order No. 2024-0015, which the Department of Health issued in November 2024 and which took effect in January 2025. Its stated objectives included institutionalizing a longer validity period for licenses and introducing an administrative reconsideration mechanism into the licensing process.
The third is the shift to digital filing. Applications now run through the FDA eServices Portal System, with product registration procedures being migrated as well under issuances such as FDA Circular No. 2026-0002 on the electronic registration of processed food products. Licensing has become faster in principle, but far less forgiving of incomplete submissions, since applications with missing documents or inconsistent data entries are rejected at pre-assessment and do not advance.
Who Must Secure an FDA License to Operate
Coverage is defined by activity rather than by company size or sales channel, and it extends well beyond factories.
- Manufacturers, Packers, and Repackers: Any establishment producing, packing, or repacking a regulated health product requires a license for each licensed activity, and manufacturers face additional technical documentation and a pre-licensing inspection.
- Refurbishers of Medical Devices: Establishments that recondition or refurbish medical devices are separately covered, reflecting the device-specific risks in reprocessed equipment.
- Traders: Businesses that contract out manufacturing while marketing products under their own name are licensed as traders, a category frequently overlooked by brand owners who assume the contract manufacturer’s license covers them.
- Distributors as Importers, Exporters, and Wholesalers: Distribution activities are licensed by function, and an establishment performing more than one function must have each function reflected in its authorization.
- Retailers of Medical and Health-Related Devices: Retail of medical devices carries its own licensing route, introduced through dedicated circulars and consolidated under the current licensing order.
- Pharmaceutical Outlets: Drugstores, community and institutional pharmacies, boticas, and retail outlets for non-prescription drugs are all covered establishments with their own personnel requirements.
- Clinical Research Organizations and Sponsors: Entities conducting or sponsoring clinical research on health products fall within the coverage of the current licensing order.
- Household and Urban Hazardous Substance Establishments and Pest Control Operators: These establishments are regulated through the cosmetics and household hazardous substances center, and their licensing procedures were onboarded to the eServices portal during 2025.
A verifiable physical address is fundamental across every category. The agency inspects premises, warehouses, and offices, and applications require location details and site information, so a purely virtual operation with no inspectable facility cannot be licensed.
Validity Periods and What Determines Them
One of the most consequential changes under the current licensing order is that validity now depends on enterprise size rather than applying uniformly across all applicants.
Under Administrative Order No. 2024-0015, an initial License to Operate is valid for three years for micro and small enterprises and six years for medium and large enterprises. A renewed license is valid for six years for micro and small enterprises and twelve years for medium and large enterprises. This replaced the earlier regime under Administrative Order No. 2020-0017, in which an initial license ran for two years and a renewal for five, with bottled water renewals limited to three.
Enterprise size follows the classification under Republic Act No. 9501, the Magna Carta for Micro, Small, and Medium Enterprises, measured by total assets: micro at not more than PHP 3,000,000, small from PHP 3,000,001 to PHP 15,000,000, medium from PHP 15,000,001 to PHP 100,000,000, and large above PHP 100,000,000. Total assets include those arising from loans but exclude the land on which the office, plant, and equipment are situated.
Approved variations do not extend the license. The validity of an approved major or minor variation follows the remaining validity of the existing LTO, reckoned from the date of approval, which means a mid-term change of address or activity does not reset the clock.
Step-by-Step Process for Securing an FDA License to Operate
The sequence below reflects how an application actually moves, and most delays occur at the earliest stages rather than the latest.
Step 1: Confirm the correct license category and activity. Identify the product category and every activity to be licensed, since a food manufacturer, a cosmetics distributor, and a drug importer are evaluated under different rules and requirements.
Step 2: Complete the underlying business registrations. Secure the Department of Trade and Industry certificate for a sole proprietorship, the Securities and Exchange Commission registration and articles for a corporation or partnership, or the Cooperative Development Authority registration for a cooperative, plus barangay and mayor’s permits for the operating address.
Step 3: Establish and document the premises. Secure the facility, warehouse, or office, and prepare proof of occupancy or ownership together with the location plan and geographic coordinates required in the electronic application form.
Step 4: Appoint the Qualified Person. Designate a Qualified Person meeting the credential requirements for the establishment type, and secure their Professional Regulation Commission identification where a licensed profession is required.
Step 5: Prepare the technical documentation. Manufacturers prepare a Site Master File and a Risk Management Plan, which are presented to inspectors during the pre-licensing inspection, along with the documents identified in the field office inspection agenda.
Step 6: File through the FDA eServices Portal System. Applications are submitted online using a declared, unalterable official email address within the control of the establishment’s authorized and qualified personnel, since all notifications and the application summary are transmitted to that address.
Step 7: Clear pre-assessment. The agency checks the submission for completeness and consistency against the uploaded requirements, and applications with missing documents or data inconsistencies are not accepted and do not proceed.
Step 8: Settle the Order of Payment on time. The Order of Payment for the application fee is valid for ten working days from issuance, and non-payment within that period automatically disapproves the application and forfeits the pre-assessment fee, with the disapproval treated as final.
Step 9: Undergo pre-licensing inspection where required. Initial manufacturer applications and household hazardous substance applications include a pre-licensing inspection by the relevant regional field office, resulting in a certificate of compliance or a recommendation for disapproval.
Step 10: Complete technical evaluation and receive the electronic license. Following evaluation and approval, the license is issued electronically for printing on standard A4 paper in full color and portrait orientation, carries a QR code verifier, and must be displayed in the most conspicuous place within the establishment.
Core Documentary Requirements
Requirements vary by activity and product category, but a common core applies to nearly every initial application.
- Accomplished Electronic Application Form: The prescribed online form, including the self-declaration, declaration, and undertaking components required by current regulations.
- Proof of Business Name Registration: The Department of Trade and Industry certificate, the Securities and Exchange Commission certificate with articles of incorporation, the Cooperative Development Authority certificate with articles of cooperation, or the charter or equivalent registration for government-owned or controlled corporations.
- Business Permit: A mayor’s permit or equivalent business permit, particularly where the establishment address differs from the address on the business name registration.
- Proof of Income or Capitalization: The latest audited financial statement with a balance sheet, or a duly notarized statement or certification of initial capitalization for new establishments, which also supports the enterprise classification that determines license validity.
- Location Plan and Geographic Coordinates: Filled into the electronic application form, used to locate the establishment for inspection purposes.
- Qualified Person Details and Credentials: The name of the Qualified Person appropriate to the establishment type, together with the valid Professional Regulation Commission identification, where the role requires a licensed professional.
- Site Master File and Risk Management Plan: Required for manufacturers and presented to inspectors during inspection, rather than merely uploaded, along with any contract manufacturing or outsourcing agreements, where applicable.
- Proof of Payment: Evidence of settlement of the prescribed fees, which currently follow the schedule in force while the new fee schedule remains suspended, with the one percent Legal Research Fund added to licensing fees.
The Qualified Person Requirement
The Qualified Person is not a formality. Under the current licensing order, this role carries defined accountability, and appointing the wrong person is a common cause of delay and disapproval.
Every covered establishment must have at least one Qualified Person, defined as a full-time employee with technical competence relevant to the establishment’s activities and health products by virtue of profession, training, or experience. During employment, that person must not be connected with, employed by, or engaged by any other FDA-regulated establishment.
Drug establishments follow the pharmacist supervision requirement under Section 31 of Republic Act No. 10918, the Philippine Pharmacy Act, so the person in charge must be a registered and licensed pharmacist. For other categories, the agency may allow a single Qualified Person to cover one establishment holding multiple licensed activities under the same business name registration, ownership, office address, and warehouse address, with pharmaceutical manufacturers, packers, repackers, and certain retail outlets excluded from that accommodation.
The role’s duties include ensuring that documentary and technical submissions are true and correct, that prescribed formats are followed, that communications with the agency on filings, post-market surveillance, and inspections are timely, that the establishment continuously complies with regulatory standards, and that changes are reported through the appropriate major or minor variation application. Consultants, liaison officers, and freelancers engaged for licensing transactions are not recognized as Authorized Persons or Qualified Persons.
Renewal Rules, Deadlines, and Surcharges
Renewal is where most licensed establishments create avoidable exposure, and the rules changed twice in 2025.
- The Standard Filing Window Is 90 Days: Under Administrative Order No. 2024-0015, a renewal application is filed within ninety calendar days prior to the expiration of the license’s validity date.
- The Interim Extension Was Introduced and Then Lifted: Beginning 17 February 2025, FDA Advisory No. 2025-0095 accepted renewal filings within 180 days before expiry as an interim measure. That extension was lifted through FDA Advisory No. 2025-0095-A in July 2025, returning the filing window to ninety days. Establishments still planning around a one-hundred-eighty-day window will find their filing rejected as premature.
- Automatic Renewal Has Its Own Conditions: An application for automatic renewal is made within three months before the validity date and requires the accomplished electronic application form, filing before the expiration date, payment of the prescribed renewal fee upon filing, and a sworn declaration and undertaking that there has been no change or variation in the establishment, subject to the exceptions in the order.
- Timely Filing Preserves the License: Where an establishment has made a timely and sufficient renewal application for an activity of a continuing nature, the existing license does not expire until the agency has rendered its regulatory decision.
- Late Filing Triggers Compounding Penalties: A renewal filed after expiry is subject to a surcharge equivalent to twice the renewal licensing fee, plus an additional ten percent per month or fraction of a month of continuing non-submission, up to a maximum of 120 days.
- Beyond 120 Days, the License Is Gone: After the one-hundred-twenty-day period, the license is considered expired, and the application is charged the total surcharge or penalty plus the initial filing fee and must undergo the initial filing and evaluation procedure. The commercial consequence is severe, since an establishment reverting to its initial filing also reverts to the shorter initial validity period.
- Renewals and Variations Are Filed Separately: A renewal application and a variation application cannot be combined, so a change in address, activity, or Qualified Person must be processed on its own track.
Strategies for Mastering the FDA License to Operate
The following measures separate establishments that treat licensing as a managed process from those that treat it as a recurring emergency.
- Build the Licensing Timeline Backward From the Commercial Date
Work from the intended launch, importation, or tender date back through product registration, license issuance, inspection, evaluation, payment, and pre-assessment. Each stage receives its own internal deadline, and the business plan is set against the last of them rather than the first.
Where importation is involved, remember that customs release depends on the importer’s license being valid at the time of entry, not merely applied for.
- Verify Enterprise Classification Before Filing
Because validity now turns on total assets under the Magna Carta for Micro, Small, and Medium Enterprises, the classification supported by the audited financial statement or capitalization certificate directly determines whether the license runs for three years or six.
Establishments approaching a classification threshold should understand the effect before filing, since the difference between a six-year and a twelve-year renewal is a material administrative saving.
- Treat the Ninety-Day Renewal Window as a Hard Calendar Event
Diarize the window opening and a target filing date well inside it, and note that filings made too early are rejected, while filings made late trigger doubled fees and compounding penalties.
Because the interim one-hundred-eighty-day extension was lifted in July 2025, internal calendars and vendor instructions created during that period need to be corrected rather than carried forward.
- Institutionalize the Qualified Person Role
Document the Qualified Person’s duties, maintain current credentials on file, and identify a qualified successor in advance so a resignation becomes a variation filing rather than an operational stoppage.
Keep the declared official email address under institutional control rather than a personal account, since every notification, order of payment, and decision is delivered there.
- Maintain a Permanent Inspection File
Keep the Site Master File, Risk Management Plan, personnel records, standard operating procedures, and supplier documentation current and physically available at the licensed premises, rather than assembling them ahead of each inspection.
Treat routine inspections, which may occur at any time during the validity of the license, as the normal condition rather than an exceptional event.
- Track Issuances Continuously
The licensing framework has changed through an administrative order, multiple advisories, and a series of circulars within a short period, including the migration of specific establishment types to the eServices portal.
Assign responsibility for monitoring agency issuances and reviewing their effect on the establishment’s filings each quarter, rather than discovering a change at renewal time.
Key Takeaways
The FDA license to operate is the foundation of any regulated health product business in the Philippines. The current framework is more generous in duration than the one it replaced, but it is also stricter in mechanics: filings must be complete at pre-assessment, payments must land inside a ten-working-day window, the renewal window has returned to ninety days, and letting a license lapse beyond one hundred twenty days sends the establishment back to initial filing with a shorter validity and a larger bill.
Businesses that treat licensing as a governed process, with an accountable Qualified Person, a documented inspection file, a verified enterprise classification, and a calendar built around the agency’s actual deadlines, secure the authorization once and keep it. Those who treat it as paperwork tend to pay twice, first in penalties and then in lost commercial time.
Reach Out for Expert Assistance
Triple i Consulting is available to help you secure and maintain your FDA License to Operate, from confirming the correct license category and preparing your documentary and technical requirements to filing through the eServices portal, preparing for pre-licensing inspection, and managing renewals and variations on schedule.
By partnering with our team, you can avoid pre-assessment rejections and lapse penalties, keep your license aligned with your actual activities and sites, and move on to product registration without losing commercial time. Contact us today to schedule an initial consultation with one of our experts:
- Contact Us Here
- Fill out the form below
- Call us at: +63 (02) 8540-9623
- Send an email to: info@tripleiconsulting.com
